<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05021549</url>
  </required_header>
  <id_info>
    <org_study_id>morbid obese parturient</org_study_id>
    <nct_id>NCT05021549</nct_id>
  </id_info>
  <brief_title>Apneic Oxygenation for Morbid Obese Parturient in cs</brief_title>
  <official_title>Effectiveness of Apneic Oxygenation for Morbid Obese Parturient Performing Elective Caesarean Section Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effect of apneic preoxygenation to conventional&#xD;
      preoxygenation on the oxygen desaturation in morbid obese parturient performing elective&#xD;
      caesarean section under general anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anesthetic management of the obese parturient is challenging. Both pregnancy and obesity are&#xD;
      risk factors for a difficult airway and anesthesia-related maternal mortality. There is&#xD;
      increased risk of difficult intubation associated with an increased difficultly in mask&#xD;
      ventilation and increased risk of accelerated desaturation during apnea.&#xD;
&#xD;
      The use of apneic oxygenation for the optimization of peri-intubation conditions is a&#xD;
      promising means of preventing hypoxemia.&#xD;
&#xD;
      Despite the recommendation of the use of nasal prongs to insufflate oxygen at flows of 5&#xD;
      L/min to 15 L/min during the apneic period randomized controlled trial is still not available&#xD;
      in the morbidly obese parturient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">October 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Morbid obesity parturient defined as a body mass index (BMI) above 40 kg/m2.&#xD;
ASA physical status I-II&#xD;
Age above 18 years.&#xD;
Scheduled for elective caesarean section under general anesthesia.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the lowest oxygen saturation recorded</measure>
    <time_frame>during intubation procedure</time_frame>
    <description>percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rates of desaturation below SpO2 90%</measure>
    <time_frame>during intubation procedure</time_frame>
    <description>percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of critical desaturation below SpO2 80%</measure>
    <time_frame>during intubation procedure</time_frame>
    <description>percentage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>nasal prong.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the apneic preoxygenation group (30 patients), will receive 10 L/ min of O2 via nasal prong.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the conventional preoxygenation group (30 patients)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal prong</intervention_name>
    <description>apneic preoxygenation group (30 patients), will receive 10 L/ min of O2 via nasal prong during preintubation apnia</description>
    <arm_group_label>nasal prong.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Morbid obesity parturient defined as a body mass index (BMI) above 40 kg/m2.&#xD;
&#xD;
          2. ASA physical status I-II&#xD;
&#xD;
          3. Age above 18 years.&#xD;
&#xD;
          4. Scheduled for elective caesarean section under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Parturient of ASA physical status III or above.&#xD;
&#xD;
          2. Suspected or known difficult airway (Mallampati class &gt; 2, reduced neck movement,&#xD;
             reduced mouth opening, or Cormack-Lehane grade 4 recorded during a previous intubation&#xD;
             procedure).&#xD;
&#xD;
          3. Any contraindication for nasal prong use, for example, tumours, fractures or trauma.&#xD;
&#xD;
          4. SpO2 â‰¤ 97% prior to preoxygenation.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams university</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama Ibrahim Mansour, MD</last_name>
      <phone>26857539</phone>
      <phone_ext>202</phone_ext>
      <email>Vice.research@med.asu.edu.eg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty of medicine</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vice Research</last_name>
      <phone>20226857539</phone>
      <email>Vice.research@med.asu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 20, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Wael Elswefi</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all IPD to be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>after finishing the study</ipd_time_frame>
    <ipd_access_criteria>clinicaltrial web site</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

